Christina Oppermann

MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2– advanced breast cancer: the multinational randomized phase III study

Qing Yuan Zhang, Tao Sun, Yong Yin et al. · Therapeutic Advances in Medical Oncology · 2020 · 102 citations · Full text

Proliferative effects of five traditional Nigerian medicinal plant extracts on human breast and bone cancer cell lines

Nadja Engel, Christina Oppermann, Abiodun Falodun et al. · Journal of Ethnopharmacology · 2011 · 86 citations

Human Breast, Oncology, Medicine +8

Effects of a common pharmaceutical, atorvastatin, on energy metabolism and detoxification mechanisms of a marine bivalve Mytilus edulis

Halina Falfushynska, Eugene P. Sokolov, Fouzia Haider et al. · Aquatic Toxicology · 2018 · 78 citations

Aquatic Food System, Energy Metabolism, Marine Biotechnology +8

Bintrafusp Alfa for Recurrent or Metastatic Cervical Cancer After Platinum Failure

Michael J. Birrer, Guiling Li, Mayu Yunokawa et al. · JAMA Oncology · 2024 · 21 citations · Full text

MONARCHplus: A phase III trial of abemaciclib plus nonsteroidal aromatase inhibitor (NSAI) or fulvestrant (F) for women with HR+/HER2- advanced breast cancer (ABC)

Z. Jiang, Xiaolin Hu, Q. Zhang et al. · Annals of Oncology · 2019 · 15 citations

Breast Oncology, Oncology, Medicine +11